Mode
Text Size
Log in / Sign up

Friedreich ataxia

Part of Hereditary ataxia

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Friedreich ataxia

10 trials tracked for Friedreich ataxia: 2 in phase 3 or 4.

10Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 6 Other / NA 2
  1. Phase 4 An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia Completed
  2. Phase 3 A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia Completed
  3. Phase 2 Interferon Gamma-1b in Friedreich Ataxia (FRDA) Completed
  4. Phase 2 FRDA Investigator Initiated Study (IIS) With Elamipretide Completed
  5. Phase 2 Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia Completed
  6. Phase 2 Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia Completed
Show 4 more trials
  1. Phase 2 NAD+ Precursor Supplementation in Friedreich's Ataxia Completed
  2. Phase 2 A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia Completed
  3. N/A Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia Completed
  4. N/A Neurology Measures in FA Children Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Hereditary ataxia

Related studies from across the Hereditary ataxia family.